Search is Powered by Google
Medical Devices / Diagnostics News

Beaumont Doctor Invents Device To Improve Blood Clot Treatment Outcomes

Main Category: Medical Devices / Diagnostics
Also Included In: Blood / Hematology
Article Date: 24 Sep 2008 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
<A HREF="http://www.mlclick.com/mlcl.php?aid=B1F0C1D32D0A9D9782E1C424695C5C0C" target="_blank"><IMG SRC="http://www.mlclick.com/mltr.php?aid=B1F0C1D32D0A9D9782E1C424695C5C0C&b=2" WIDTH="300" HEIGHT="250" BORDER="0" alt="41st World Forum for Medicine, International Trade Fair with Congress"></A>


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The Beaumont Commercialization Center, a medical device development company within Beaumont Hospitals, has a new surgical instrument available for licensing.

Paul J. Arpasi, M.D., a Beaumont radiologist, developed a device that will help reduce the risk for excessive bleeding and infection by allowing multiple catheters or other devices to be connected to a patient from a single puncture site.

When treating a patient, there is often a need to use more than one type of drug or medical device. This creates a need for more than one access site. Any time an access site is used, there is increased risk for excessive bleeding and infection, so it is ideal to keep the number of access sites to a minimum.

This new device has multiple access ports that allow thrombolytic catheters or other devices, such as wires, snares, and low-profile angioplasty balloons to be simultaneously connected to a patient through a single puncture site.

Multiple simultaneous ports can facilitate:

-- multiple concurrent selective thrombolyses

-- complex foreign body retrieval

-- increased surface area of drug delivery within large caliber vessels

-- multiple low profile angioplasties in patients where multiple access points are not available

"The need to insert multiple devices or deliver more than one type of drug to a patient is very common and this invention helps to make that faster, easier, and less invasive," said Dr. Arpasi. "I'm grateful for the opportunity to improve this procedure and to help in reducing patient's risk of complications."

About the Beaumont Commercialization Center

Part of Beaumont Hospitals, headquartered in Royal Oak, MI, the Beaumont Commercialization Center is a hospital-based medical device development resource focused on helping manufacturers and inventors bring their ideas for new medical devices and technology to reality. The full-service center blends product development knowledge with the experience of physicians and clinical staff at Beaumont Hospitals.

The Beaumont Commercialization Center offers intellectual property, design engineering, prototype services, usability testing, clinical trials, and regulatory assistance. For more information about the Beaumont Commercialization Center, visit http://www.beaumontcommercializationcenter.com

The Beaumont Commercialization Center
http://www.beaumontcommercializationcenter.com




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
FDA Approves KAPIDEX (dexlansoprazole) Delayed-Release Capsules For The Treatment Of GERD
03 Feb 2009
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration (FDA) approved KAPIDEX™ (dexlansoprazole)...


Diagnosing Vision Problems in Children
Diagnosing Vision Problems in Children

Children with vision problems are often misidentified as having learning disabilities, especially since the kids themselves may not be aware there's a problem with their sight. But parents should look for warning signs of vision trouble.

more videos are available in our health videos section.